Increasing costs reduce kidney transplant volumes in Nigeria, indicating a need for system improvements.
There was a progressive increase in the patient-borne cost associated with kidney transplantation, with a reduction in transplant volumes per year. Cost of medications (especially induction regimen) and HLA-tissue typing appear to weigh more on the total cost than other items.
No takes yet. Share an insight, caveat, or question.
Okwuonu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: